Steven Michael Oliveira 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-29 11:44 am Purchase |
2024-04-22 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 791,235 8.890% |
693,032 (+705.71%) |
Filing |
| 2023-08-18 10:50 am Sale |
2023-08-08 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 98,203 3.890% |
-24,395 (-19.90%) |
Filing |
| 2022-10-07 12:46 pm Purchase |
2022-09-14 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 122,598 8.080% |
83,297 (+211.94%) |
Filing |
| 2021-04-14 5:17 pm Purchase |
2021-04-12 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 39,301 13.870% |
16,061 (+69.11%) |
Filing |
| 2021-04-05 06:01 am Purchase |
2021-04-01 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 23,240 8.200% |
23,240 (New Position) |
Filing |